Do you want to read an article? Please log in or register.
Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis
Psoriatic ArthritisRheumatoid Arthritis